Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Soft tissue sarcomas: update on molecular data].

M Bui Nguyen Binh1, F Collin, J-M Coindre

  • 1Département de Pathologie, Institut Bergonié et Université Victor-Segalen, Bordeaux, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circumcision and Risk of Febrile Urinary Tract Infection in Boys with Posterior Urethral Valves: Result of the CIRCUP Randomized Trial.

European urology·2021
Same author

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.

ESMO open·2021
Same author

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma.

Oncoimmunology·2020
Same author

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

EBioMedicine·2019
Same author

Intra-articular nodular fasciitis of the proximal interphalangeal joint of a finger: A case report.

Hand surgery & rehabilitation·2019
Same author

Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Cone-beam computed tomography-based radiomics for tumour regression assessment during radiotherapy of non-small-cell lung cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Genetic analysis, including translocations and gene amplifications, aids in diagnosing rare soft tissue sarcomas and predicting patient outcomes. These molecular markers are crucial for targeted therapies and detecting microscopic disease.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Pathology

Context:

  • Soft tissue sarcomas (STS) are rare malignancies presenting diagnostic and therapeutic challenges.
  • Understanding the genetic landscape of STS is critical for accurate classification and management.

Purpose:

  • To review the role of genetic alterations in the diagnosis, prognosis, and treatment of soft tissue sarcomas.
  • To highlight specific genetic markers and their clinical utility in various STS subtypes.

Summary:

  • Four main types of genetic disorders in STS include translocations, gene amplifications, mutations, and complex genomic imbalances.
  • Specific translocations are vital for diagnosing synovial sarcoma, alveolar rhabdomyosarcoma, and PNET, guiding therapeutic decisions, and confirming rarer STS types.
  • Gene amplifications (MDM2, CDK4) and mutations (KIT, PDGFRA) are valuable for diagnosing liposarcomas and gastrointestinal stromal tumors (GIST), respectively, with mutation type predicting treatment response.

Related Experiment Videos

  • Sensitive detection techniques enable the identification of microscopic metastases, such as bone marrow metastasis in alveolar rhabdomyosarcoma.

    • Impact:

    • Molecular diagnostics improve the accuracy of STS classification and prognosis determination.
    • Identification of specific genetic alterations facilitates personalized treatment strategies, particularly for sarcomas with therapeutic consequences.
    • Advanced detection methods enhance the sensitivity for identifying minimal residual disease, potentially improving patient monitoring and outcomes.